Made O'Meter
Discover where a brand or product originates
Aimovig
ownerNovartis AG (Switzerland)
originUnited States and Switzerland
Aimovig is owned by Novartis AG, headquartered in Switzerland. No. The ultimate owner of Aimovig, Novartis AG, is headquartered in Switzerland, not in the United States.
Novartis is a leading global medicines company headquartered in Switzerland, focusing on innovative therapies and diverse medical solutions across various therapeutic areas including neuroscience.
Novartis Norge AS
Products from Aimovig (1)
- Aimovig (erenumab) 140 mg injection · Pharmaceutical – Migraine prophylaxis medication (CGRP inhibitor)
disclaimer
poweredBy